Tañeza, Baby Girl .

HRN: 22-54-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
AMPICILLIN 250MG (VIAL)
01/30/2023
02/06/2023
IV
130 Mg
Q12
PSNB
Waiting Final Action 
01/30/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/30/2023
02/06/2023
IV
40 Mg
Q24
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: